Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

181. WHO public health research agenda for influenza: short version

WHO public health research agenda for influenza: short version WHO public health research agenda for influenza: short version JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links WHO public health research agenda for influenza: short version, 2017 update View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. WHO public health research (...) agenda for influenza: short version, 2017 update. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description 17 p. Gov't Doc # WHO/WHE/IHM/GIP/2017.9 Collections Language English Metadata Related items Showing items related by title and MeSH subject.  World Health Organization (‎ WHO/WHE/IHM/GIP/2017.4 , 2017 )‎  World Health Organization (‎ WHO/WHE/IHM/GIP/2017.10 , 2017 )‎  World Health Organization (‎ WHO/WHE/IHM/GIP/2017.5 , 2017 )‎ View Item

2017 WHO

182. WHO public health research agenda for influenza: reducing the risk of emergence of a pandemic influenza

WHO public health research agenda for influenza: reducing the risk of emergence of a pandemic influenza WHO public health research agenda for influenza: reducing the risk of emergence of a pandemic influenza JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links WHO public health research agenda for influenza: reducing the risk of emergence of a pandemic influenza, 2017 update View (...) / Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. WHO public health research agenda for influenza: reducing the risk of emergence of a pandemic influenza, 2017 update. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description 25 p. Gov't Doc # WHO/WHE/IHM/GIP/2017.4 Collections Language English Metadata Related items Showing items related by title and MeSH subject.  Organización Mundial de la Salud (‎ WHO/WHE/IHM/GIP/2017.2 , 2017 )‎  World

2017 WHO

183. WHO public health research agenda for influenza: limiting the spread of pandemic, zoonotic and seasonal epidemic influenza

WHO public health research agenda for influenza: limiting the spread of pandemic, zoonotic and seasonal epidemic influenza WHO public health research agenda for influenza: limiting the spread of pandemic, zoonotic and seasonal epidemic influenza JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links WHO public health research agenda for influenza: limiting the spread of pandemic (...) , zoonotic and seasonal epidemic influenza, 2017 update View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. WHO public health research agenda for influenza: limiting the spread of pandemic, zoonotic and seasonal epidemic influenza, 2017 update. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description 32 p. Gov't Doc # WHO/WHE/IHM/GIP/2017.5 Collections Language English Metadata Related items Showing items related by title and MeSH subject

2017 WHO

184. WHO public health research agenda for influenza: minimizing the impact of pandemic, zoonotic, and seasonal epidemic influenza

WHO public health research agenda for influenza: minimizing the impact of pandemic, zoonotic, and seasonal epidemic influenza WHO public health research agenda for influenza: minimizing the impact of pandemic, zoonotic, and seasonal epidemic influenza JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links WHO public health research agenda for influenza: minimizing the impact (...) of pandemic, zoonotic, and seasonal epidemic influenza, 2017 update View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. WHO public health research agenda for influenza: minimizing the impact of pandemic, zoonotic, and seasonal epidemic influenza, 2017 update. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description 37 p. Gov't Doc # WHO/WHE/IHM/GIP/2017.10 Collections Language English Metadata Related items Showing items related by title and MeSH

2017 WHO

185. Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses

Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza - review of recent systematic reviews and meta-analyses SCIENTIFIC ADVICE www.ecdc.europa.eu Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza Review of recent systematic reviews and meta-analyses ECDC SCIENTIFIC ADVICE Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza – review of recent systematic reviews and meta-analyses ii (...) (University of Michigan School of Public Health); Jonathan Nguyen-Van-Tam (University of Nottingham) ECDC representatives: Mike Catchpole; Piotr Kramarz; Pasi Penttinen; Angus Nicoll; Kari Johansen; Emmanuel Robesyn; Eeva Broberg; René Snacken; Cornelia Adlhoch; Brenna Deckert; Luciana Muresan Suggested citation: European Centre for Disease Prevention and Control. Expert opinion on neuraminidase inhibitors for the prevention and treatment of influenza – review of recent systematic reviews and meta

2017 European Centre for Disease Prevention and Control - Expert Opinion

186. Avian influenza A (H5N1) virus infection

Avian influenza A (H5N1) virus infection Avian influenza A (H5N1) virus infection - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Avian influenza A (H5N1) virus infection Last reviewed: February 2019 Last updated: September 2018 Summary Notifiable condition. Infection control measures, such as standard, droplet, contact, and airborne precautions, are recommended. High case-fatality rate of approximately 53% among (...) . Definition A contagious disease of animals caused by viruses that infect birds and, less commonly, pigs. Avian influenza A viruses are highly species-specific but have infected other mammals and, on rare occasions, have crossed the species barrier to infect humans. Highly pathogenic avian influenza (HPAI) A H5N1 virus originating in poultry and wild birds can be transmitted to humans, with rare cases of infection transmitted between humans. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person

2017 BMJ Best Practice

187. Effectiveness of workplace social distancing measures in reducing influenza transmission: a systematic review

Effectiveness of workplace social distancing measures in reducing influenza transmission: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2017 PROSPERO

188. Systematic review of disease burden of influenza in Bangladesh, India, Nepal and Sri Lanka

Systematic review of disease burden of influenza in Bangladesh, India, Nepal and Sri Lanka Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2017 PROSPERO

189. Influenza vaccine response during the start of a pandemic: report of the second WHO informal consultation held in Geneva, Switzerland, 21 - 22 July 2016

Influenza vaccine response during the start of a pandemic: report of the second WHO informal consultation held in Geneva, Switzerland, 21 - 22 July 2016 Influenza vaccine response during the start of a pandemic: report of the second WHO informal consultation held in Geneva, Switzerland, 21 - 22 July 2016 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Influenza vaccine (...) response during the start of a pandemic: report of the second WHO informal consultation held in Geneva, Switzerland, 21 - 22 July 2016 View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. Influenza vaccine response during the start of a pandemic: report of the second WHO informal consultation held in Geneva, Switzerland, 21 - 22 July 2016. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description 29 p. Gov't Doc # WHO/HSE/PED/GIP/EPI/2017.1

2017 WHO

190. The efficacy, effectiveness and immunogenicity of the influenza vaccine in Africa: a systematic review

The efficacy, effectiveness and immunogenicity of the influenza vaccine in Africa: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2017 PROSPERO

191. Systematic review of influenza vaccine: morning versus afternoon vaccination

Systematic review of influenza vaccine: morning versus afternoon vaccination Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2017 PROSPERO

192. Inclusion of safety/ADR-related outcomes in economic evaluations for seasonal influenza vaccines: a review of available studies

Inclusion of safety/ADR-related outcomes in economic evaluations for seasonal influenza vaccines: a review of available studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2017 PROSPERO

193. Effect of repeat vaccination on vaccine-induced protection against laboratory-confirmed influenza infection: a systematic review of randomized controlled trials and observational studies

Effect of repeat vaccination on vaccine-induced protection against laboratory-confirmed influenza infection: a systematic review of randomized controlled trials and observational studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2017 PROSPERO

194. Herd effect of influenza immunization: a systematic review

Herd effect of influenza immunization: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures Timing

2017 PROSPERO

195. Efficacy and effectiveness of 2009 pandemic influenza A(H1N1) vaccines: a systematic review and meta-analysis

Efficacy and effectiveness of 2009 pandemic influenza A(H1N1) vaccines: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation

2017 PROSPERO

196. Isolation and phylogenetic characterization of haemagglutinin and neuraminidase genes of H9N2 low pathogenicity avian influenza virus isolated from commercial layers in India (PubMed)

Isolation and phylogenetic characterization of haemagglutinin and neuraminidase genes of H9N2 low pathogenicity avian influenza virus isolated from commercial layers in India Avian influenza is a highly infectious and dynamically evolving disease of birds causing high morbidity and mortality. It is caused by avian influenza virus (AIV) that belongs to the family Orthomyxoviridae. Two types of AIV have been described based on their pathogenicity viz. highly pathogenic avian influenza virus (...) that causes severe disease with high mortality and low pathogenic avian influenza virus (LPAI) that generally causes asymptomatic infection or a mild disease. The H9N2 subtype is the widely circulated LPAI type in the world. The H9N2 subtype of was first reported from northern India in March 2003. However, systematical surveillance information for the evolution of H9N2 viruses in poultry flocks of Southern India is lacking. The present study reports the isolation and characterization of H9N2 isolates from

Full Text available with Trip Pro

2016 Virusdisease

197. Knowledge of H7N9 avian influenza and intention to adopt preventive behaviours among Chinese poultry farmers: a cross-sectional study. (PubMed)

Knowledge of H7N9 avian influenza and intention to adopt preventive behaviours among Chinese poultry farmers: a cross-sectional study.

2016 Lancet

198. Risk for Congenital Malformation With H1N1 Influenza Vaccine: A Cohort Study With Sibling Analysis. (PubMed)

Risk for Congenital Malformation With H1N1 Influenza Vaccine: A Cohort Study With Sibling Analysis. Earlier studies reporting varying risk estimates for congenital malformation in offspring of mothers undergoing vaccination against H1N1 influenza during pregnancy did not consider the potential role of confounding by familial (genetic and shared environmental) factors.To evaluate an association between maternal H1N1 vaccination during pregnancy and offspring malformation, with familial factors (...) taken into account.Population-based prospective study.Sweden.Liveborn offspring born between 1 October 2009 and 1 October 2011 to mothers receiving monovalent AS03-adjuvanted H1N1 influenza vaccine (Pandemrix [GlaxoSmithKline]) during pregnancy. A total of 40 983 offspring were prenatally exposed to the vaccine, 14 385 were exposed within the first trimester (14 weeks), and 7502 were exposed during the first 8 weeks of pregnancy. Exposed offspring were compared with 197 588 unexposed offspring

2016 Annals of Internal Medicine

199. Influenza infection modulates vesicular trafficking and induces Golgi complex disruption (PubMed)

Influenza infection modulates vesicular trafficking and induces Golgi complex disruption Influenza A virus (IFV) replicates its genome in the nucleus of infected cells and uses the cellular protein transport system for genome trafficking from the nucleus to the plasma membrane. However, many details of the mechanism of this process, and its relationship to subsequent cytoplasmic virus trafficking, have not been elucidated. We examined the effect of nuclear transport inhibitors Leptomycin B (LB (...) the export of virus. Inhibition of vesicular trafficking by BFA, NOC, and ZWEHD also affected influenza infection. Interestingly, IFV infection induced fragmentation of the Golgi complex resulting in diffuse distribution of large and small vesicles throughout the cytoplasm. Live-cell microscopy revealed expansion of Golgi localization signals indicating progressive dispersion of Golgi positive structures, resulting in the disassembly of the Golgi ribbon structure. Other vesicular components (Rab1b, ARF1

Full Text available with Trip Pro

2016 Virusdisease

200. Acute posterior multifocal placoid pigment epitheliopathy and granulomatous uveitis following influenza vaccination (PubMed)

Acute posterior multifocal placoid pigment epitheliopathy and granulomatous uveitis following influenza vaccination To report a case of acute placoid multifocal posterior pigment epitheliopathy (APMPPE) following influenza vaccination. The patient exhibited granulomatous uveitis during the recovery phase.A woman in her thirties developed flu-like symptoms seven days after receiving an influenza vaccination. Approximately 2 weeks later, the patient reported with conjunctival injection, blurred (...) , and macular edema were observed and were treated with topical steroid eye drops. No systemic disorders including sarcoidosis, tuberculosis, and Wegener's granulomatosis were present.As influenza vaccinations are administered worldwide, ophthalmologists should be aware of the ocular side effects following vaccination. Although rare, the possibility of APMPPE occurrence following influenza vaccination should be considered; additionally, the recovery phase of APMPPE may be associated with granulomatous

Full Text available with Trip Pro

2016 American journal of ophthalmology case reports